Evidence map›Paper›PMID 31646023›Full record

ArticleBiomedical optics express2019

Quantitative assessment of changes in cellular morphology at photodynamic treatment

A V Belashov, A A Zhikhoreva, T N Belyaeva, N N Nikolsky, I V Semenova, E S Kornilova, O S Vasyutinskii

Open access · goldAbstract read
In one paragraph

Article in Biomedical optics express, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

A V BelashovIoffe Institute; 26, Polytekhnicheskaya, St. Petersburg, 194021, Russia.
A A ZhikhorevaIoffe Institute; 26, Polytekhnicheskaya, St. Petersburg, 194021, Russia.
T N BelyaevaInstitute of Cytology of RAS; 4, Tikhoretsky pr., St. Petersburg, 194064, Russia.
N N NikolskyInstitute of Cytology of RAS; 4, Tikhoretsky pr., St. Petersburg, 194064, Russia.
I V SemenovaIoffe Institute; 26, Polytekhnicheskaya, St. Petersburg, 194021, Russia.
E S KornilovaInstitute of Cytology of RAS; 4, Tikhoretsky pr., St. Petersburg, 194064, Russia.
O S VasyutinskiiIoffe Institute; 26, Polytekhnicheskaya, St. Petersburg, 194021, Russia.
Ioffe Institute · RUInstitute of Cytology · RUPeter the Great St. Petersburg Polytechnic University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Temporal dependence of changes in the morphological characteristics of cells of two cultured lines of cancer origin, HeLa and A549, induced by photodynamic treatment with Radachlorin photosensitizer, have been monitored using digital holographic microscopy during first two hours after short-term irradiation. The observed post-treatment early dynamics of the phase shift in the transmitted wavefront indicated several distinct scenarios of cell behavior depending upon the irradiation dose. In particular the phase shift increased at low doses, which can be associated with apoptosis, while at high doses it decreased, which can be associated with necrosis. As shown, the two cell types responded differently to similar irradiation doses. Although the sequence of death scenarios with the increase of the irradiation dose was the same, each scenario was realized at substantially different doses. These findings suggest that the average phase shift of the transmitted wavefront can be used for quantitative non-invasive cell death characterization. The conclusions made were cofirmed by commonly used test assays using confocal fluorescent microscopy.

Identifiers

PMID31646023
PMCPMC6788599
OpenAlexW2898694808

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.